Kainova Therapeutics has secured $32m CAD in a Series B [...]
Confo Therapeutics has selected CFTX-2034, an SSTR5 agonist antibody, as [...]
Kainova Therapeutics has secured $32m CAD in a Series B [...]
Confo Therapeutics has selected CFTX-2034, an SSTR5 agonist antibody, as [...]